See analyst estimates and all valuation multiples for Biopharmaceuticals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $925B | 14.8x | 33.0x | |
| $509B | 5.4x | 14.3x | |
| $457B | 7.5x | 17.8x | |
| $339B | 4.4x | 11.2x | |
| $305B | 5.2x | 15.0x | |
| $277B | 5.0x | 12.1x | |
| $264B | 4.1x | 9.1x | |
| $218B | 4.5x | 9.4x | |
| $214B | 5.9x | 12.0x | |
| $190B | 3.0x | 7.7x | |
| $168B | 5.8x | 10.7x | |
| $140B | 2.9x | 7.8x | |
| $126B | 2.4x | 8.0x | |
| $117B | 2.7x | 8.0x | |
| $106B | 8.9x | 20.7x | |
| $81.0B | 10.1x | 20.0x | |
| $77.8B | 1.5x | 7.0x | |
| $71.0B | 2.9x | 10.0x | |
| $70.8B | 2.4x | 9.1x | |
| $67.9B | 4.2x | 12.6x | |
| $57.3B | 6.1x | 13.9x | |
| $53.7B | 11.6x | 38.8x | |
| $53.7B | 11.5x | 38.5x | |
| $51.8B | 5.6x | 18.9x | |
| $47.1B | 2.7x | 9.3x | |
| $44.7B | 7.2x | 25.2x | |
| $38.8B | 3.0x | 14.5x | |
| $35.9B | 3.2x | 15.0x | |
| $29.4B | 1.9x | 7.8x | |
| $29.1B | 10.5x | 29.9x | |
| $28.4B | 2.9x | 9.3x | |
| $28.2B | 13.7x | 35.3x | |
| $26.4B | 1.9x | 6.4x | |
| $26.2B | 2.0x | 8.7x | |
| $23.7B | 7.9x | 8.3x | |
| $22.3B | 2.2x | 6.2x | |
| $20.8B | 60.1x | 38.8x | |
| $17.8B | 9.5x | 69.3x | |
| $17.2B | 2.0x | 8.1x | |
| $16.5B | 4.5x | 11.9x | |
| $16.3B | 110.6x | 208.9x | |
| $14.8B | 5.2x | 22.3x | |
| $14.7B | 3.2x | 11.7x | |
| $14.4B | 10.3x | 31.3x | |
| $14.0B | 4.6x | 12.4x | |
| $13.9B | 4.6x | 12.0x | |
| $13.8B | 29.7x | -1629.6x | |
| $13.0B | 2.2x | 13.2x | |
| $12.3B | 3.8x | 15.9x | |
| $12.2B | 2.1x | 14.2x | |
| $12.2B | 44.3x | -257.0x | |
| $11.8B | 3.8x | 9.5x | |
| $11.6B | 0.3x | 5.4x | |
| $11.4B | n/a | n/a | |
| $11.4B | 3.0x | 12.3x | |
| $11.1B | 2.5x | 6.7x | |
| $10.7B | 12.8x | 41.9x | |
| $10.5B | 6.8x | 27.3x | |
| $10.5B | 3.8x | 13.6x | |
| $10.3B | 3.7x | 14.6x | |
| $10.3B | 3.1x | 7.5x | |
| $10.1B | 1.6x | 12.8x | |
| $10.1B | 4.6x | 12.5x | |
| $10.0B | 1.6x | 5.2x | |
| $9.7B | 2.5x | 10.0x | |
| $9.1B | 944.9x | -42.1x | |
| $8.7B | n/a | n/a | |
| $8.1B | 1.6x | 12.5x | |
| $8.1B | 6.1x | 9.4x | |
| $7.9B | n/a | n/a | |
| $7.9B | 3.1x | 4.8x | |
| $7.4B | 2.0x | 9.8x | |
| $7.2B | 4.6x | 23.2x | |
| $6.9B | 2.2x | 9.8x | |
| $6.9B | 93.2x | -3817.5x | |
| $6.8B | 3.6x | 17.6x | |
| $6.4B | 2.7x | 8.3x | |
| $6.4B | 8.5x | 31.2x | |
| $6.4B | 16.4x | -560.0x | |
| $6.3B | 5.4x | 18.3x | |
| $6.2B | 2.1x | 9.1x | |
| $6.2B | 2.0x | 8.2x | |
| $6.2B | 7984.8x | -21.2x | |
| $6.2B | 1.4x | 8.1x | |
| $5.9B | 1.8x | 7.0x | |
| $5.9B | 3.5x | 19.1x | |
| $5.9B | 3.9x | 45.0x | |
| $5.8B | n/a | n/a | |
| $5.7B | n/a | -21.4x | |
| $5.6B | 15.5x | 22.9x | |
| $5.4B | 11.2x | 34.7x | |
| $5.3B | n/a | n/a | |
| $5.2B | 2.7x | 10.6x | |
| $5.0B | 1.8x | 4.9x | |
| $5.0B | 5.9x | 29.1x | |
| $4.9B | 5.8x | 20.3x | |
| $4.9B | 8.4x | 25.7x | |
| $4.7B | 9.4x | 20.6x | |
| $4.7B | 9.3x | 24.3x | |
| $4.7B | 13.2x | -66.5x | |
| $4.6B | n/a | -28.4x | |
| $4.6B | 10.8x | 32.9x | |
| $4.5B | 4.8x | 13.9x | |
| $4.3B | n/a | -11.0x | |
| $4.2B | 3.0x | 11.0x | |
| $4.2B | 1.6x | 9.0x | |
| $4.2B | n/a | n/a | |
| $3.9B | 34.4x | -400.5x | |
| $3.8B | 3.7x | 17.1x | |
| $3.7B | 4.3x | 16.2x | |
| $3.7B | 2.5x | 9.5x | |
| $3.6B | 2.1x | 10.6x | |
| $3.6B | 10.2x | -389.6x | |
| $3.5B | n/a | -31.7x | |
| $3.4B | 5.0x | 14.0x | |
| $3.4B | 73.8x | -17.2x | |
| $3.4B | 2.5x | 8.9x | |
| $3.3B | 10.6x | 65.8x | |
| $3.3B | 4.9x | 15.3x | |
| $3.2B | 115.1x | n/a | |
| $3.2B | 2.5x | 11.9x | |
| $3.2B | 6.5x | -1195.8x | |
| $3.2B | 4.6x | n/a | |
| $3.0B | 7.1x | -45.8x | |
| $3.0B | 5.2x | 23.6x | |
| $3.0B | 1.4x | 9.4x | |
| $2.9B | n/a | -12.5x | |
| $2.8B | 36.3x | -22.4x | |
| $2.8B | 13.8x | 23.2x | |
| $2.8B | 4.2x | 28.2x | |
| $2.7B | 10.8x | -150.9x | |
| $2.7B | 6.7x | 20.1x | |
| $2.7B | 4.3x | 10.5x | |
| $2.6B | 4.0x | 13.5x | |
| $2.6B | n/a | n/a | |
| $2.5B | 19.7x | -173.5x | |
| $2.5B | n/a | -11.6x | |
| $2.4B | 9.6x | -6.6x | |
| $2.4B | 3.4x | 18.2x | |
| $2.4B | 2.8x | 13.6x | |
| $2.3B | n/a | -12.0x | |
| $2.3B | 43.3x | n/a | |
| $2.3B | 2.9x | 18.5x | |
| $2.2B | 12.1x | 35.8x | |
| $2.2B | 2.6x | 9.8x | |
| $2.1B | 3.4x | 13.5x | |
| $2.1B | 5.6x | 16.2x | |
| $2.1B | 6.8x | 17.7x | |
| $2.1B | 11.6x | 49.4x | |
| $2.0B | 13.5x | n/a | |
| $2.0B | 2.6x | 4.4x | |
| $2.0B | 7.5x | 64.3x | |
| $2.0B | 7.3x | 28.5x | |
| $1.8B | 4.7x | 12.4x | |
| $1.8B | 7.8x | -71.3x | |
| $1.8B | 54.8x | -9.1x | |
| $1.8B | n/a | -10.8x | |
| $1.8B | 13.8x | 55.3x | |
| $1.8B | n/a | n/a | |
| $1.8B | 6.4x | n/a | |
| $1.8B | 0.8x | 4.5x | |
| $1.7B | 4.1x | 14.5x | |
| $1.7B | 14.1x | -30.1x | |
| $1.7B | 2.5x | 11.7x | |
| $1.7B | 15.9x | 316.6x | |
| $1.7B | 4.0x | n/a | |
| $1.6B | n/a | -18.4x | |
| $1.6B | 166.2x | -12.5x | |
| $1.6B | 10.9x | 27.1x | |
| $1.6B | 2.1x | 5.9x | |
| $1.5B | 8.3x | 285.4x | |
| $1.5B | n/a | n/a | |
| $1.5B | 30.0x | 113.7x | |
| $1.5B | 585.1x | n/a | |
| $1.4B | n/a | n/a | |
| $1.4B | n/a | n/a | |
| $1.4B | n/a | n/a | |
| $1.4B | 5.9x | 33.9x | |
| $1.4B | 3.5x | -307.7x | |
| $1.4B | 4.8x | 9.5x | |
| $1.4B | 13.7x | n/a | |
| $1.3B | 4.7x | 26.6x | |
| $1.3B | 8.1x | -4.8x | |
| $1.3B | 3.2x | n/a | |
| $1.3B | 37.0x | -11.6x | |
| $1.2B | 1.3x | 5.3x | |
| $1.2B | n/a | n/a | |
| $1.2B | 0.5x | 6.0x | |
| $1.2B | 2.5x | 14.1x | |
| $1.2B | n/a | -6.4x | |
| $1.2B | 444.2x | -7.8x | |
| $1.1B | n/a | n/a | |
| $1.1B | 3.2x | 26.5x | |
| $1.1B | 1.9x | -66.8x | |
| $1.1B | 2.8x | 39.7x | |
| $1.1B | n/a | -7.0x | |
| $1.1B | 18.0x | n/a | |
| $1.1B | 2.9x | 12.4x | |
| $1.1B | n/a | -5.3x | |
| $1.1B | 6.5x | -7.4x | |
| $1.1B | 9.5x | -9.2x | |
| $1.0B | 3.5x | 7.1x | |
| $1.0B | n/a | n/a | |
| $1.0B | 1.2x | 5.1x | |
| $1.0B | 1.7x | -7.4x | |
| $1.0B | 8.7x | 28.4x | |
| $1.0B | 1049.0x | -10.4x | |
| $996M | n/a | n/a | |
| $974M | 2.5x | 2.9x | |
| $916M | 2.7x | 35.1x | |
| $912M | n/a | -7.1x | |
| $897M | n/a | -8.8x | |
| $866M | 1.4x | 7.0x | |
| $864M | n/a | -7.5x | |
| $853M | 36.4x | -3.5x | |
| $837M | 1.9x | 8.9x | |
| $799M | 6.3x | -4.9x | |
| $765M | 56.5x | n/a | |
| $764M | n/a | n/a | |
| $751M | 59.3x | -2.3x | |
| $747M | n/a | -5.1x | |
| $746M | 7.5x | 45.2x | |
| $746M | 2.7x | 11.6x | |
| $745M | n/a | n/a | |
| $728M | n/a | -4.8x | |
| $721M | n/a | n/a | |
| $704M | n/a | -4.9x | |
| $696M | n/a | -4.8x | |
| $691M | 20.0x | -10.9x | |
| $680M | 86517.9x | -6.0x | |
| $674M | 71.6x | -5.7x | |
| $663M | 15.1x | 122.3x | |
| $653M | 6.2x | 22.9x | |
| $626M | 35.1x | -8.1x | |
| $614M | 92.0x | -3.9x | |
| $603M | n/a | n/a | |
| $576M | 3.4x | 21.0x | |
| $566M | n/a | -2.6x | |
| $556M | 526.1x | -28.4x | |
| $556M | 43.1x | 86.3x | |
| $543M | 27.8x | -173.3x | |
| $540M | n/a | n/a | |
| $538M | n/a | n/a | |
| $516M | 20398.2x | n/a | |
| $505M | n/a | n/a | |
| $492M | 7.6x | -22.5x | |
| $481M | 4.9x | 13.7x | |
| $476M | 35.1x | -10.3x | |
| $461M | n/a | n/a | |
| $446M | 2.3x | -4.0x | |
| $432M | 18.5x | -8.5x | |
| $429M | n/a | n/a | |
| $421M | 2.2x | 9.4x | |
| $418M | 9.0x | -6.1x | |
| $418M | 1.3x | 9.3x | |
| $414M | 1.4x | 11.6x | |
| $410M | 1.2x | 4.7x | |
| $399M | 69.1x | -1.8x | |
| $398M | 2.7x | -3.1x | |
| $386M | 73.0x | -12.2x | |
| $381M | 6.0x | 23.6x | |
| $381M | 36036.6x | -4.2x | |
| $380M | 3.1x | 51.0x | |
| $369M | 19.0x | -1282.2x | |
| $328M | 1.8x | 7.6x | |
| $326M | 0.9x | 9.8x | |
| $322M | n/a | n/a | |
| $319M | n/a | -22.5x | |
| $318M | 10.1x | -1.6x | |
| $309M | n/a | n/a | |
| $309M | 4.5x | 33.7x | |
| $305M | 1.3x | n/a | |
| $299M | 21.8x | -6.9x | |
| $291M | 6.8x | n/a | |
| $284M | 4.3x | 9.4x | |
| $276M | 2.8x | 8.8x | |
| $274M | n/a | -40.7x | |
| $263M | n/a | n/a | |
| $260M | n/a | n/a | |
| $259M | n/a | n/a | |
| $259M | n/a | n/a | |
| $258M | 5.6x | 43.8x | |
| $254M | 6.3x | -31.1x | |
| $254M | n/a | n/a | |
| $248M | 12.6x | -5.8x | |
| $239M | n/a | -2.1x | |
| $236M | n/a | n/a | |
| $235M | 2.7x | -10.7x | |
| $234M | 12.8x | n/a | |
| $233M | 1.7x | 15.7x | |
| $228M | 60.1x | -5.0x | |
| $223M | n/a | n/a | |
| $210M | 250.9x | -5.3x | |
| $195M | n/a | n/a | |
| $193M | 4.4x | 21.5x | |
| $192M | 23.5x | -6.2x | |
| $191M | 2.9x | n/a | |
| $188M | 39.9x | -2.8x | |
| $172M | n/a | -3.1x | |
| $166M | 5.6x | n/a | |
| $158M | n/a | n/a | |
| $158M | 28.3x | -11.6x | |
| $155M | 1.9x | -4.7x | |
| $154M | 23.1x | -1.7x | |
| $153M | n/a | n/a | |
| $147M | 45.0x | -2.7x | |
| $144M | 16.9x | -6.4x | |
| $140M | 8.2x | -2.6x | |
| $132M | 2.4x | 132.0x | |
| $132M | n/a | n/a | |
| $132M | n/a | n/a | |
| $132M | 5.4x | -3.6x | |
| $128M | n/a | n/a | |
| $126M | 18.4x | -11.4x | |
| $122M | 8.1x | -3.0x | |
| $120M | 1.9x | n/a | |
| $116M | n/a | n/a | |
| $111M | n/a | n/a | |
| $111M | 27.0x | -8.0x | |
| $110M | n/a | -8.4x | |
| $107M | n/a | n/a | |
| $106M | 79.3x | -20.9x | |
| $106M | 1.5x | 9.2x | |
| $103M | 7.0x | 23.9x | |
| $99.5M | n/a | n/a | |
| $98.0M | 20.4x | -0.7x | |
| $96.7M | 18.5x | -10.3x | |
| $95.0M | 1.3x | -0.4x | |
| $94.7M | 4.8x | -19.6x | |
| $91.3M | 9.0x | -3.4x | |
| $89.4M | 2.9x | -1.2x | |
| $87.6M | n/a | n/a | |
| $85.6M | n/a | n/a | |
| $84.8M | n/a | n/a | |
| $83.6M | n/a | n/a | |
| $77.7M | n/a | n/a | |
| $72.4M | n/a | n/a | |
| $72.3M | 2.9x | 11.5x | |
| $69.9M | n/a | n/a | |
| $65.0M | n/a | n/a | |
| $60.1M | n/a | n/a | |
| $57.7M | n/a | n/a | |
| $57.0M | n/a | n/a | |
| $55.7M | 882.6x | -9.0x | |
| $53.0M | 5.4x | 2.4x | |
| $51.8M | 7.1x | n/a | |
| $51.6M | 970.2x | n/a | |
| $50.2M | 0.5x | -0.8x | |
| $45.9M | n/a | n/a | |
| $45.2M | 9.3x | n/a | |
| $44.7M | 32.3x | -55.1x | |
| $43.2M | n/a | n/a | |
| $43.1M | n/a | -2.4x | |
| $41.6M | 54.4x | -4.1x | |
| $41.4M | 1.6x | 11.7x | |
| $38.8M | 9.9x | n/a | |
| $38.1M | n/a | n/a | |
| $36.8M | n/a | -5.8x | |
| $35.4M | n/a | n/a | |
| $35.0M | 1.9x | 43.4x | |
| $34.1M | n/a | n/a | |
| $33.9M | n/a | n/a | |
| $33.6M | n/a | n/a | |
| $32.3M | 9.7x | -7.8x | |
| $32.3M | 8.4x | n/a | |
| $32.2M | n/a | n/a | |
| $30.9M | n/a | n/a | |
| $30.1M | n/a | n/a | |
| $28.8M | 3.8x | -1.5x | |
| $27.9M | 44.2x | -2.7x | |
| $27.6M | n/a | n/a | |
| $27.4M | n/a | n/a | |
| $27.3M | n/a | -15.1x | |
| $26.7M | 27.6x | n/a | |
| $25.4M | n/a | n/a | |
| $24.2M | 25.7x | -0.3x | |
| $24.0M | n/a | -5.6x | |
| $22.5M | n/a | -6.8x | |
| $21.5M | n/a | n/a | |
| $21.5M | n/a | n/a | |
| $21.3M | 14.1x | -0.7x | |
| $20.0M | 15.4x | -7.3x | |
| $19.7M | n/a | n/a | |
| $19.2M | 2.8x | 7.8x | |
| $18.4M | n/a | n/a | |
| $18.3M | n/a | n/a | |
| $18.3M | 16.9x | -4.9x | |
| $18.1M | n/a | n/a | |
| $17.4M | n/a | n/a | |
| $17.4M | n/a | -5.9x | |
| $17.2M | n/a | n/a | |
| $16.8M | n/a | -8.3x | |
| $16.7M | n/a | -4.0x | |
| $15.5M | 6.4x | -2.0x | |
| $15.4M | n/a | n/a | |
| $15.4M | n/a | n/a | |
| $15.4M | 6.3x | 1.7x | |
| $15.3M | 2.8x | -5.7x | |
| $14.9M | n/a | n/a | |
| $14.2M | n/a | n/a | |
| $13.7M | 0.1x | -0.3x | |
| $13.3M | n/a | n/a | |
| $13.2M | n/a | n/a | |
| $12.1M | n/a | n/a | |
| $11.8M | n/a | n/a | |
| $11.4M | 153.3x | -5.3x | |
| $11.3M | n/a | n/a | |
| $11.1M | n/a | n/a | |
| $11.1M | 1.9x | -1.2x | |
| $10.3M | 10.6x | -22.9x | |
| $10.2M | 7.2x | -27.3x | |
| $10.2M | n/a | n/a | |
| $9.9M | n/a | n/a | |
| $9.9M | 0.7x | -3.1x | |
| $9.6M | n/a | n/a | |
| $9.0M | n/a | n/a | |
| $8.0M | n/a | n/a | |
| $7.9M | n/a | n/a | |
| $7.8M | 9.9x | -0.6x | |
| $7.6M | 2.3x | -2.9x | |
| $7.6M | n/a | -8.2x | |
| $7.4M | 13.4x | -0.6x | |
| $7.3M | n/a | n/a | |
| $7.3M | n/a | -2.1x | |
| $7.3M | n/a | -1.9x | |
| $7.2M | 14.5x | n/a | |
| $6.9M | n/a | n/a | |
| $6.6M | n/a | -1.2x | |
| $6.3M | n/a | n/a | |
| $6.0M | 53.2x | -2.0x | |
| $6.0M | 3.4x | -0.4x | |
| $5.7M | n/a | n/a | |
| $4.9M | n/a | n/a | |
| $4.7M | n/a | n/a | |
| $4.3M | n/a | n/a | |
| $4.2M | 3.2x | -1.1x | |
| $3.9M | n/a | n/a | |
| $3.5M | n/a | n/a | |
| $3.3M | n/a | n/a | |
| $3.2M | n/a | n/a | |
| $2.9M | n/a | n/a | |
| $2.9M | n/a | -1.7x | |
| $2.8M | n/a | n/a | |
| $2.5M | n/a | n/a | |
| $2.5M | n/a | n/a | |
| $2.1M | 2.5x | n/a | |
| $1.9M | n/a | n/a | |
| $1.7M | n/a | n/a | |
| $1.7M | n/a | n/a | |
| $1.5M | n/a | -1.9x | |
| $1.5M | n/a | n/a | |
| $1.4M | n/a | n/a | |
| $1.3M | n/a | n/a | |
| $0.7M | n/a | n/a | |
| $0.5M | n/a | n/a | |
| $0.3M | n/a | n/a | |
| $0.2M | n/a | n/a | |
| $0.1M | n/a | n/a | |
| -$0.1M | -0.0x | 0.0x | |
| -$0.2M | n/a | n/a | |
| -$0.4M | n/a | n/a | |
| -$0.5M | n/a | n/a | |
| -$0.8M | n/a | n/a | |
| -$0.8M | -1.8x | 0.1x | |
| -$1.1M | -15.7x | 0.3x | |
| -$4.6M | n/a | 0.4x | |
| -$6.3M | n/a | n/a | |
| -$35.0M | -40.6x | n/a | |
| -$105M | n/a | 0.6x | |
| -$114M | -5.2x | 0.7x | |
| -$1.5B | -4.7x | 5.6x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Biopharmaceuticals